The Medicines Company to Announce Fourth-Quarter and Full-Year 2016 Financial Results on February 28, 2017

17 Feb 2017

The Medicines Company (NASDAQ:MDCO) will host a conference call on Tuesday, February 28, 2017, at 8:30 a.m., Eastern Time, to discuss fourth-quarter and full-year 2016 financial results and operational developments.

The dial-in information to access the call is listed below:

U.S./Canada: (877) 359-9508
International: (224) 357-2393
Conference ID: 66296847

A taped replay of the conference call will be available from 11:30 a.m., Eastern Time, following the conference call until 11:30 a.m., Eastern Time, on March 7, 2017. The replay may be accessed as follows:

U.S./Canada: (855) 859-2056
International: (404) 537-3406
Conference ID: 66296847

The webcast can be accessed in the Investors section of The Medicines Company website. A replay of the webcast will also be available.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose — to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in three critical therapeutic areas: serious infectious disease care, cardiovascular care and surgery and perioperative care. The Company is headquartered in Parsippany, New Jersey, with global innovation centers in California and Switzerland.


The Medicines Company
Meg Langan
Vice President, 973-290-6319
Investor Relations
Krishna Gorti, M.D., 973-290-6122
Vice President, Investor Relations

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information